Clearside Biomedical Inc. (CLSD) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Clearside Biomedical Inc.

NASDAQ: CLSD · Real-Time Price · USD
4.37
0.30 (7.37%)
At close: Oct 03, 2025, 3:59 PM
4.29
-1.83%
After-hours: Oct 03, 2025, 07:30 PM EDT

Clearside Biomedical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
492K 2.33M 306K 1.04M 90K 230K 6.34M 859K 1.02M 4K 330K 266K 384K 347K 25.69M 3.07M 780K 34K
Cost of Revenue
84K 248K 149K n/a 44K 28K 20K 142K 213K n/a 204K n/a 38K n/a 3.89M n/a n/a n/a
Gross Profit
408K 2.08M 157K 1.04M 90K 202K 6.33M 717K 805K 4K 126K 266K 346K 347K 21.8M 3.07M 780K 34K
Operating Income
-3.57M -5.21M -7.15M -5.93M -7.59M -8.21M -2.92M -7.05M -7.27M -7.61M -8.07M -6.72M -7.84M -7.65M 18.71M -4.89M -6.1M -8.35M
Interest Income
115K 163K 358K 338K 419K 348K n/a 409K 458K 492K n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-4.5M -7.51M -7.31M -7.69M -7.59M -11.76M -4.83M -9.27M -9.11M -9.28M -9.66M -7.83M -7.81M -7.64M 18.71M -4.89M -6.09M -7.35M
Net Income
-4.5M -8.22M -7.31M -7.69M -7.59M -11.76M -4.83M -9.27M -9.11M -9.28M -8.59M -7.83M -7.79M -7.64M 18.71M -4.89M -6.09M -7.35M
Selling & General & Admin
2.48M 2.82M 3.06M 2.84M 3.08M 2.82M 2.95M 2.64M 3.13M 3.16M 3.17M 2.35M 2.79M 3.46M 3.14M 2.82M 2.82M 2.89M
Research & Development
1.58M 4.46M 4.24M 4.13M 4.6M 5.59M 6.29M 5.13M 4.95M 4.45M 5.03M 4.64M 5.43M 4.54M 3.84M 5.15M 4.06M 5.49M
Other Expenses
-84K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 24K 2K 2K 2K 1K n/a
Operating Expenses
3.98M 7.29M 7.31M 6.97M 7.68M 8.41M 9.24M 7.77M 8.07M 7.61M 8.2M 6.99M 8.22M 7.99M 6.98M 7.96M 6.88M 8.38M
Interest Expense
2.76M 2.67M 2.58M 2.46M 2.34M 2.4M 2.28M 2.62M 2.29M 2.17M 2.04M 1.3M n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
4.06M 7.54M 7.46M 6.97M 7.68M 8.44M 9.26M 7.91M 8.29M 7.61M 8.4M 6.99M 8.22M 7.99M 6.98M 7.96M 6.88M 8.38M
Income Tax Expense
n/a 715K n/a n/a n/a n/a n/a -16K n/a n/a -1.07M n/a -24K -2K n/a n/a n/a n/a
Shares Outstanding (Basic)
5.19M 5.13M 5.06M 4.98M 4.98M 4.66M 4.16M 4.13M 4.11M 4.08M 4.03M 4.01M 4.01M 4M 3.98M 3.96M 3.85M 3.8M
Shares Outstanding (Diluted)
5.19M 5.13M 5.06M 4.98M 4.98M 4.66M 4.16M 4.13M 4.11M 4.08M 4.03M 4.01M 4.01M 4M 4.08M 3.96M 3.85M 3.8M
EPS (Basic)
-0.87 -1.65 -1.44 -1.5 -1.5 -2.55 -1.16 -2.25 -2.25 -2.25 -2.1 -1.95 -1.95 -1.95 4.65 -1.23 -1.65 -1.95
EPS (Diluted)
-0.87 -1.65 -1.44 -1.5 -1.5 -2.55 -1.16 -2.25 -2.25 -2.25 -2.1 -1.95 -1.95 -1.95 4.65 -1.23 -1.65 -1.95
EBITDA
-3.57M -4.75M -4.65M -5.16M -5.21M -9.33M -2.54M -6.63M -6.8M -7.1M -7.6M -6.49M -7.78M -7.6M 18.75M -4.84M -6.05M -8.3M
EBIT
-1.73M -4.83M -4.73M -5.23M -5.25M -9.36M -2.56M -6.64M -6.81M -7.11M -7.62M -6.53M -7.81M -7.64M 18.71M -4.89M -6.1M -8.35M
Depreciation & Amortization
84K 85K 79K 75K 44K 28K 20K 16K 16K 15K 22K 39K 38K 46K 45K 44K 44K 45K